Lactulose and Maxipime drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lactulose (lactulose) and Maxipime (cefepime hydrochloride). Common drug interactions include hepatic cirrhosis among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Lactulose and Maxipime. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Lactulose?

Lactulose has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 46,960 Lactulose users. Check the latest studies of Lactulose.

What is Maxipime?

Maxipime has active ingredients of cefepime hydrochloride. eHealthMe is studying from 4,279 Maxipime users. Check the latest studies of Maxipime.



On Jul, 18, 2026

53 people who take Lactulose and Maxipime together, and have interactions are studied.

Lactulose and Maxipime drug interactions.

What are the common drug interactions of Lactulose and Maxipime, by gender? *:

female:

  1. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  2. Anaemia (lack of blood)
  3. Diarrhoea
  4. Hepatic failure (liver failure)
  5. Pleural effusion (water on the lungs)
  6. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  7. Encephalopathy (functioning of the brain is affected by some agent or condition)
  8. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  9. Jaundice cholestatic
  10. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)

male:

  1. Pneumonia
  2. Blood urea increased
  3. Cough
  4. Depression
  5. Discomfort
  6. Emotional distress
  7. Exostosis (formation of new bone on the surface of a bone)
  8. Haematochezia (passage of stools containing blood)
  9. Inguinal hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)
  10. Intervertebral disc degeneration (spinal disc degeneration)

What are the common drug interactions of Lactulose and Maxipime, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Pyrexia (fever)
  2. Rash

40-49:

  1. Pleural effusion (water on the lungs)
  2. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  3. Infection
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Renal failure (kidney dysfunction)
  6. Acute respiratory failure
  7. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  8. Angina pectoris (chest pain due to ischemia of the heart muscle)
  9. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  10. Anxiety

50-59:

  1. Fatigue (feeling of tiredness)
  2. Glaucoma (increased fluid pressure in the eye with vision loss)
  3. Hypophagia (reduced food intake)
  4. Injury
  5. Mucosal inflammation (infection of mucous membrane)
  6. Neoplasm malignant (cancer tumour)
  7. Neuralgia (pain in one or more nerves)
  8. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  9. Prostate cancer
  10. Rash pruritic (redness with itching)

60+:

  1. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  2. Platelet count decreased
  3. Decreased appetite
  4. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  5. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  6. Pyrexia (fever)
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Anaemia (lack of blood)
  9. Blood lactate dehydrogenase increased
  10. Blood phosphorus increased

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 14 people, 26.42%
  2. Pneumonia: 6 people, 11.32%
  3. Febrile Neutropenia (fever with reduced white blood cells): 6 people, 11.32%
  4. High Blood Pressure: 6 people, 11.32%
  5. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 5 people, 9.43%
  6. Thrombocytopenia (decrease of platelets in blood): 4 people, 7.55%
  7. Fever: 4 people, 7.55%
  8. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 7.55%
  9. Liver Disorder (liver diseases): 4 people, 7.55%
  10. Hypokalemia (low potassium): 3 people, 5.66%

* Approximation only. Some reports may have incomplete information.

Do you take Lactulose and Maxipime?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lactulose and Maxipime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lactulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Maxipime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lactulose and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Maxipime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lactulose and cefepime hydrochloride (the active ingredients of Lactulose and Maxipime, respectively), and Lactulose and Maxipime (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: